The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Endocrinology
(Mar 2022)
Editorial: Refractory Pituitary Adenoma—Current Challenges and Emerging Treatments
Renzhi Wang,
Cuiqi Zhou,
Ann I. McCormack,
Adam N. Mamelak
Affiliations
Renzhi Wang
Department of Neurosurgery, Peking Union Medical College Hospital (CAMS), Beijing, China
Cuiqi Zhou
Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States
Ann I. McCormack
Department of Endocrinology, St Vincent’s Hospital Sydney, Darlinghurst, NSW, Australia
Adam N. Mamelak
Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States
DOI
https://doi.org/10.3389/fendo.2022.868174
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
refractory pituitary adenomas
diagnosis
surgical treatment
medical therapy
temozolomide, targeted and immunotherapy
drug resistance
WeChat QR code
Close